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Abstract
Two erythromycin-resistant strains of Bordetella pertussis were
isolated from nasopharyngeal specimens of two asymptomatic
schoolchildren in China. High-resolution melting and sequencing
analyses confirmed the homogeneous A2047G mutation in 23S
rRNA genes of the two isolates. High-resolution melting (HRM)
analysis is a useful assay for the rapid detection of erythromycin-
resistant B. pertussis. The appearance of erythromycin-resistant
B. pertussis strains in China is alarming.
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Introduction
Pertussis is an acute respiratory tract infection, and is mainly
caused by Bordetella pertussis. The disease primarily affects
neonates and infants. An increased incidence of pertussis has
been found in adults and adolescents in regions where the
coverage of vaccination against pertussis in young children is
high. The infected adults and adolescents usually constitute an
unrecognized but significant source of infection for neonates
and infants. Erythromycin has traditionally been the drug of
choice for the treatment and prophylaxis of pertussis. Since
1994, erythromycin-resistant isolates have been occasionally
reported [1–3], and they have been isolated from infants with
severe symptoms. In China, the primary choice of drug for the
treatment and prophylaxis of pertussis is erythromycin. In this
article, we describe, for the first time, two B. pertussis strains
isolated from asymptomatic schoolchildren and shown to be
resistant to erythromycin.
We conducted a cross-sectional study on pertussis sero-
prevalence and B. pertussis carriage status among healthy
adolescents in Shandong province, China, during the period
July–September 2011. In this province, DTaP or DTwP vaccine
is administered in the third, fourth and fifth months of life, and
a booster dose of DTaP vaccine is given at 18–24 months.
Booster vaccinations in older children and adolescents are not
given in China. During the study, a total of 150 nasopharyngeal
swabs were taken from identical subjects for B. pertussis
culture and PCR. Of thse, two were culture-positive and seven
were PCR-positive. Two erythromycin-resistant B. pertussis
strains were isolated from healthy adolescents without
coughing for at least 3 months before blood sampling. They
were an 11-year-old boy and a 9-year-old boy, both without
cough, sore throat, headaches, or fever symptoms, and they
did not develop any respiratory symptoms during a 3-month
follow-up. They had completed injection of DTwP vaccine in
childhood, according to the national immunization programme,
and lived in the same county. None of their household
contacts had a history of cough in the 3 months before the
study started. Moreover, the two children and their house-
holds stated that they had not taken any antibiotics before
entering the study. Nasopharyngeal swabs were obtained from
the two children, but not from their household members. Two
nasopharyngeal swabs that were culture-positive for B. pertus-
sis had their positivity confirmed by PCR. The culture plates
contained charcoal agar supplemented with 10% defibrinated
sheep blood. The identification of two isolates (Bph201101 and
Bph201102) was based on biochemical reactions and slide
agglutination with specific B. pertussisis antisera. Susceptibility
testing was performed for erythromycin with Etest gradient
strips and a 15-lg erythromycin disk on charcoal agar. The
MIC of erythromycin was >256 mg/L for both. Two isolates
showed growth confluent to the disk.
The two isolates harboured an allele combination of ptxA1/
ptxP1/tcfA2. However, the prn allele of the two isolates could
not be identified by PCR with the primers and protocol
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recommended for genotyping [4]. The two isolates had the
pulsed-field gel electrophoresis profiles BpFINR9 and BpSR23;
they belonged to the same cluster (cluster III), and resembled
those strains circulating in Europe before the 1990s [5].
Bph201101 and Bph201102 were serotype Fim2 and Fim2,3,
respectively. PCR-based sequencing was used to determine
whether the resistance to erythromycin was caused by a
mutation of the 23S rRNA gene of B. pertussis, as described by
Bartkus et al. [1]. The sequences of an approximately 521-bp
PCR fragment were determined for Bph201101 and
Bph201102, together with two erythromycin-susceptible con-
trol strains of B. pertussis ATCC 9797 (18323) and the
Chinese vaccine strain 58003. An A?G transition homozy-
gous mutation was found at position 2047 of the 23S rRNA
gene of the two clinical isolates (Fig.1b).
High-resolution melting (HRM) analysis is a powerful
technique for the detection of mutations in double-stranded
DNA samples. As compared with sequencing, HRM is rapid,
and the cost of reagents is low when a number of samples are
analysed. HRM employs saturating double-stranded DNA-
binding dyes during the PCR amplification, and denaturation of
the PCR amplicons is monitored in real time. Sequence
variants are detected from differences in the melting profiles
between test and reference DNAs [6]. Therefore, we
developed a PCR-based HRM method for specific identifica-
tion of the A2047G mutation of the 23S rRNA gene of
B. pertussis. Primers were designed to amplify fragment of
nucleotides 1930–2098 flanking the mutation (Table 1). DNAs
extracted from the clinical isolates Bph201101 and Bph201102,
the B. pertussis reference strain ATCC 9797 and the Chinese
vaccine strain 58003 were used. In each PCR reaction (20 lL),
5–30 ng of genomic DNA (5 lL) were included. The melting
curve was generated by heating in increments of 2.2°C/s, with
the temperature range shown in Table 1. To enhance differ-
entiation of the distinct homozygotes (wild type and A2047G
transition), the tested DNA samples were spiked with one-
fifth of wild-type ATCC 9797 DNA standard. A clear differ-
ence in melting curve shape was observed between DNA
samples from homozygous mutation and wild-type strains
(Fig. 1a).
In conclusion, B. pertussis is a strict human pathogen, with
no known animal or environmental reservoir. Asymptomatic
B. pertussis infection has been reported during outbreaks [7,8].
In China, the use of antibiotics is common for the treatment
and prophylaxis of all kinds of suspicious infectious diseases.
However, whether the use of erythromycin is higher in the
county where the study was performed was not known.
Owing to the passive surveillance of pertussis in China, we
do not know the prevalence of B. pertussis in schools in this
country. To our knowledge, this present study is the first to
investigate the prevalence of B. pertussis in schools. On the
basis of the results of this study, the prevalence of B. pertussis
at the studied school was 4.7% (7/150) by PCR. However,
further research with a large number of samples is needed.
Primary culture of B. pertussis from clinical samples is not
sensitive, and takes up to 7 days to obtain a clear result, which
restricts rapid detection by phenotypic analyses. The real-time
PCR and HRM analysis developed in this study has proven to
be sensitive and specific for detecting the mutation responsible
for erythromycin resistance in B. pertussis. Moreover, the
(a)
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FIG. 1. (a) High-resolution melting analysis for detection of the
A2047G mutation of 23S rRNA of the two Bordetella pertussis clinical
isolates. To enhance differentiation of the distinct homozygotes, the
tested DNA samples from the clinical isolates Bph201101 and
Bph201102 and the Chinese vaccine strain 58003 were spiked with
one-fifth wild-type ATCC 9797 DNA standard. The two red melting
curves indicate homozygous mutation in DNA samples of Bph201101
and Bph201102 with spiked ATCC 9797 DNA standard. The blue
melting curves indicate homozygous wild-type DNA samples from
ATCC 9797 DNA standard, the Chinese vaccine strain 58003 with
spiked ATCC 9797 DNA standard, and Bph201101 and Bph201102
clinical isolates without spiked ATCC 9797 DNA standard. The Tm of
the homozygous mutations was approximately 85.8°C, and the
estimated change in Tm between the homozygous wild type and
A2047G transition is approximately 0.24°C [9]. The experiments were
repeated four times for both reference strains and clinical isolates. (b)
Nucleotide sequences of the 23S rRNA genes of the two erythromy-
cin-resistant B. pertussis isolates Bph201101 and Bph201102 and the
two erythromycin-sensitive reference strains ATCC 9797 and Chinese
vaccine strain 58003. The A?G transition mutation at position 2047 is
indicated as bold type.
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method is rapid and suitable for molecular surveillance of drug
resistance in B. pertussis.
B. pertussis carries three copies of the 23S rRNAgene.Using a
combined PCR–restriction fragment length polymorphism
methodology, Bartkus et al. [1] were able to differentiate
heterozygous erythromycin-resistant strains from those with
homozygous mutation. It remains to be shown whether this
PCR-based HRM method can also identify heterozygous eryth-
romycin-resistant strains and possible newmutations other than
the A2047G transition.
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TABLE 1. Primer sequences and PCR conditions used for high-resolution melting (HRM) analysis for detection of erythromycin-
resistant Bordetella pertussis isolates
Primer name Primer sequence (5′–3′) Amplicon size PCR conditionsa HRM conditionsb
1930F1 CCTGCACGAATGGCGTAA 168 bp 95°C 2 min
95°C 10 s
95°C 1 min
40°C 1 min2098R1 CCTCCCACCTATCCTACAC
60°C 15 s
72°C 10 s
70°C 1 s
95 continuous
aA total of 40 cycles were used.
bFor HRM conditions, the acquisition mode at 95°C was set as continuous.
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